GLYMATRIX™ technology is based on a natural biochemical process called glycation. This process uses sugars to cross-link collagen molecules producing a collagen matrix. This collagen matrix can be bioprogrammed and tailored to deliver a range of products of varying physical properties and customized longevity and rate of degradation.
GLYMATRIX™ technology is a proprietary collagen cross-linking technology. This cross linking technology, utilizes a natural, sugar-based, cross-linking agent, similar to the naturally occurring process in the human body. GLYMATRIX technology delivers the well recognized benefits of collagen-based biomaterials, while designed to provide safe, effective and predictable products.
The GLYMATRIX™ technology represents a novel design of collagen-based bio-matrices. It offers the ability to specifically engineer biomaterial implants with long-lasting effects, enhanced stability and properties similar to those of natural collagen found in the body. It is ideally suited to reconstructive and aesthetic medicine because it enables biological materials to be programmed to perform in a manner appropriate to their intended application.
GLYMATRIX™ cross linking technology is the subject of several international patents. and is the culmination of years of research into glycation as a cross linking mechanism. It results in a collagen matrix that looks and feels like part of the patient's own tissue. It is expected to raise the use of collagen in cosmetic, dental and reconstructive medicine.
OSSIX® PLUS is currently Datum Dental's leading dental product based upon GLYMATRIX™ technology. OSSIX® PLUS is a resorbable collagen membrane, used in dental implant procedures. Information about OSSIX PLUS can be found in the Product section.
Please contact us for additional information about GLYMATRIX™ technology.